A KCa 2.2/2.3 Opener Reverses ET-1-Induced NLRP3 Activation in Hypertensive Mice Corpora Cavernosa
Biomolecules · 2026
DOI: 10.3390/biom16030432 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Rafael Sobrano Fais und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto 14049-900, SP, Brazil. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Endothelin-1, Hypertension, Penis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer Fund, American Heart Association, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Hypertension-induced erectile dysfunction is associated with endothelial dysfunction in the corpus cavernosum. Membrane depolarization activates the NLRP3 inflammasome, with downregulation of endothelial Ca2+-activated K+ channels type 2.3 (KCa 2.3) and upregulation of endothelin-1 (ET-1) linked to erectile dysfunction. However, underlying mechanisms remain incompletely understood. We hypothesized that activating KCa 2.2/2.3 channels reverses erectile dysfunction and ET-1-induced NLRP3 activation in hypertensive DOCA/salt mice. Hypertension was induced in mice using a DOCA/salt model, with unilaterally nephrectomized mice as controls. We measured blood pressure, intracavernous pressure (ICP), and corpus cavernosum (CC) contractility, and performed immunoblots for KCa 2.3, caspase-1, and interleukin-1β (IL-1β). DOCA/salt mice showed impaired erectile function and increased IL-1β activity and reduced KCa 2.3 expression. Treatment with the endothelin receptor antagonist bosentan or the KCa 2.2/2.3 channel opener NS13001 reversed these dysfunctions and reduced ET-1-induced NLRP3 activation. NS13001 also restored decreased currents in endothelial cells exposed to ET-1. These findings establish that hypertension-induced erectile dysfunction involves an ET-1/membrane depolarization/NLRP3 inflammasome axis in corpus cavernosum endothelial cells, and that targeting endothelial KCa 2.2/2.3 channels represents a promising therapeutic strategy to counteract erectile dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto 14049-900, SP, Brazil.
- Department of Biomedicine, Pulmonary and Cardiovascular Pharmacology, Aarhus University, 8000 Aarhus, Denmark.
- Division of Pulmonary, Critical Care, and Sleep Medicine, National Jewish Health, Denver, CO 80206, USA.
- Department of Biomedical Sciences/Animal Physiology, Faculty of Veterinary, Central University of Venezuela, Aragua 2105, Venezuela.
ORCID-Profile: Rafael Sobrano Fais, Simon Gabriel Comerma-Steffensen, Estefano Pinilla, Vladimir V Matchkov, Rita Tostes, Ulf Simonsen
Förderung
- Bayer Fund
- American Heart Association
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Novo Nordisk Foundation
- Wilhelm Pedersen and Wife's memorial
- PHAB Level 3, AHA Postdoctoral fellowship
- Sao Paulo Research Foundation
- Wilhelm Pedersen and Wife’s memorial grant
Zitieren
APA
Sobrano Fais, R., Comerma-Steffensen, S. G., Pinilla, E., Matchkov, V. V., Tostes, R., Silva Carneiro, F., & Simonsen, U. (2026). A KCa 2.2/2.3 Opener Reverses ET-1-Induced NLRP3 Activation in Hypertensive Mice Corpora Cavernosa. Biomolecules. https://doi.org/10.3390/biom16030432
Vancouver
Sobrano Fais R, Comerma-Steffensen SG, Pinilla E, Matchkov VV, Tostes R, Silva Carneiro F, et al. A KCa 2.2/2.3 Opener Reverses ET-1-Induced NLRP3 Activation in Hypertensive Mice Corpora Cavernosa. Biomolecules. 2026. doi:10.3390/biom16030432
BibTeX
@article{SobranoFais2026,
author = {Sobrano Fais, Rafael and Comerma-Steffensen, Simon Gabriel and Pinilla, Estefano and Matchkov, Vladimir V and Tostes, Rita and Silva Carneiro, Fernando and Simonsen, Ulf},
title = {A KCa 2.2/2.3 Opener Reverses ET-1-Induced NLRP3 Activation in Hypertensive Mice Corpora Cavernosa},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16030432}
}
EUVIMED